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ontrast Ultrasound Imaging
f the Carotid Artery Vasa Vasorum
nd Atherosclerotic Plaque Neovascularization
teven B. Feinstein, MD, FACC
hicago, Illinois
Cardiovascular disease is associated with the aging of the population, obesity, metabolic
syndrome, and diabetes. Therefore, it is important to develop non-invasive imaging systems
to detect “at-risk” populations. New data suggest that contrast-enhanced ultrasound (CU)
imaging of the carotid arteries enhances luminal irregularities (i.e., ulcers and plaques),
improves near-wall, carotid intima-media thickness, and uniquely permits direct, real-time
visualization of neovasculature of the atherosclerotic plaque and associated adventitial vasa
vasorum. With continued clinical investigation, CU imaging of the carotid artery may afford
an effective means to non-invasively identify atherosclerosis in “at-risk” populations while
providing new standard for therapeutic monitoring. (J Am Coll Cardiol 2006;48:236–43)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.02.068© 2006 by the American College of Cardiology Foundation
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pith approximately 1.2 million heart attacks and 750,000
trokes afflicting an aging American population each year,
ardiovascular disease remains our country’s number one
ause of death. Unfortunately, this grim statistic is likely to
orsen in the years ahead due to the prevalence of obesity,
etabolic syndrome, and clinical diabetes in the burgeoning
aby boomer population. Therefore, it is critical that we
evelop non-invasive screening methods that safely and
eliably identify surrogate markers of atherosclerosis, indi-
ating the presence of unstable plaques and an increased risk
f cardiovascular events. Once “vulnerable patients” (1–3)
re identified, it may be possible to institute timely preven-
ive therapy, monitor its effectiveness, and potentially re-
erse the course of these disease processes.
New data suggest that contrast-enhanced ultrasound (CU)
maging of the carotid arteries may help identify patients
ho are at increased risk of cardiovascular diseases. Because
U agents are currently Food and Drug Administration-
pproved only for use in imaging the heart structures, their
ff-label use in vascular imaging requires institutional re-
earch approval. Where such approval is obtained, physi-
ians can perform CU carotid imaging in the office or
ospital setting, obtaining direct real-time carotid images
ith enhanced assessment of the arterial lumen and plaque
orphology, improved resolution of carotid intima-media
hickness (c-IMT), and, importantly, direct visualization of
he adventitial vasa vasorum and plaque neovascularization
3–5). The latter is particularly significant because neovas-
ularization of the atherosclerotic plaque is considered a
redictor of vulnerable lesions in patients (6–16). Moreover,
From the Rush Presbyterian St. Luke’s Medical Center, Chicago, Illinois. The
uthor has received speaking honorarium from KOS Pharmaceutical, Takeda Phar-
aceutical, and GE Health Care, and a research grant from Takeda Pharmaceutical.w
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ccepted February 28, 2006.arotid atherosclerotic plaque appears to indicate the pres-
nce of systemic atherosclerosis. Therefore, with continued
nvestigation, CU imaging of the carotid vasa vasorum
romises to become a routine noninvasive means of identi-
ying an atherosclerotic plaque in its earliest stages. These
bservations may lead to early clinical interventions with
edical therapies (statins, anti-inflammatory medications,
ngiotensin-converting enzyme, or calcium-channel medi-
ations, and so on) or mechanical procedures (stents, carotid
ndarterectomy surgery), potentially reducing the incidence
f heart attack and stroke.
NDERSTANDING THE ROLE OF VASA
ASORUM AND PLAQUE NEOVASCULARIZATION
N THE DEVELOPMENT OF ATHEROSCLEROSIS
n atherosclerotic plaque begins to develop as a result of
amage/insult/hypoxia to the endothelial cells of the vascu-
ar system (5,17). As atherosclerosis progresses, reduced
xygen diffusion diminishes the nutrient supply reaching the
rterial wall, resulting in hypoxia. Reactive physiologic
ompensation causes a thickening of the intima-media
omplex exceeding the oxygen diffusion threshold (250 to
00 m), inducing ischemia, which then triggers a contin-
al release of angiogenic growth factors (vascular endothe-
ial growth factor, tissue hypoxic factor, and so on). It is
elieved that the absence of pericytes in some angiogenic
essels causes these immature vessels to “leak” potentially
oxious and inflammatory plasma components (hemoglo-
in, oxidized low-density lipoprotein cholesterol, lipopro-
ein[a], glucose, advanced glycation end products, and
nflammatory cells) into the extracellular matrix of the
edia/intima, increasing plaque volume. The ongoing de-
osit of plasma components appears to further reduce vessel
all oxygen diffusion, triggering continued growth of an-
g
a
a
b
s
t
s
A
w
w
m
n
t
B
n
“
w
p
a
(
t
b
r
v
a
v
a
e
“
c
a
d
g
(
c
p
A
s
v
t
o
t
a
o
a
v
i
f
a
p
n
e
i
p
s
m
f
t
a
s
t
t
e
m
C
O
R
c
s
a
1
2
3
T
u
S
t
s
a
o
a
f
c
r
C
t
n
c
s
w
v
s
237JACC Vol. 48, No. 2, 2006 Feinstein
July 18, 2006:236–43 Contrast Ultrasound: Vasa Vasorum Angiogenesisiogenesis. Ultimately, the plaque is enveloped in luxurious
dventitial vasa vasorum and intraplaque neovascularization,
hallmark of symptomatic atherosclerosis (18).
Clinician researchers have long appreciated a relationship
etween the vasa vasorum and the development of athero-
clerosis. For well over 100 years, pathologists have observed
hat the adventitial vasa vasorum serves as the primary
ource of the neovascular blood supply within plaque (19).
t autopsy, prominent angiogenic vessels were observed
ithin the media and intima of the arterial walls of patients
ith atherosclerosis. Moreover, in a pre-morbid setting, the
edia and intima tunica layers of the vessel walls received
ominal nutrient blood supply from luminal diffusion and,
o a lesser degree, from the adventitial vasa vasorum (20).
The historic work of Koster (21), Beeuwkes et al. (8), and
arger et al. (5) linked the clinical presence of angiogenic
eovascular vessels to atherosclerotic plaque; as noted:
There is no doubt that these small vessels of the arterial
all exist in far greater numbers in regions associated with
laque. Observations (were) made as early as 1876 (21)
nd confirmed in 1938 (Winternitz)” (8). Beeuwkes et al.
8) and Barger et al. (5) used postmortem cinemicrographic
echniques to demonstrate a direct anatomic connection
etween coronary adventitial vasa vasorum and atheroscle-
otic plaque. These cine films revealed arterial and venous
asa vasorum “bathing” (supplying blood to) the arterial
therosclerotic plaque in patients who suffered fatal cardio-
ascular events. Moreover, adventitial neovascularization
nd plaque neovascularization were directly linked to ath-
rosclerosis in the seminal work of Barger et al. (5):
Hypothesis: vasa vasorum and neovascularization of human
oronary arteries, a possible role in the pathophysiology of
therosclerosis.” Subsequently, in 1990, Martin et al. (19)
ashed the widely held belief that the luminal surface
enerates atherosclerosis.
More recent clinical pathologic studies by Fleiner et al.
15) demonstrated that the presence and degree of neovas-
ularization within vulnerable plaque is associated with
laque rupture and clinical occlusive cardiovascular events.
nd as Kumamoto et al. (11) observed: “There was a
ignificant positive correlation between the density of new
essels in the intima and the incidence of luminal stenosis,
he extent of chronic inflammatory infiltrate, the formation
f granulation tissue, or the atheromatous changes, whereas
he vascular density decreased in the extensively hyalinized
nd calcified intima. The newly formed intimal vessels
riginated mainly from the adventitial vasa vasorum and
lso partly from the proper coronary lumen. The intimal
Abbreviations and Acronyms
c-IMT  carotid intima-media thickness
CU  contrast-enhanced ultrasound
MRI  magnetic resonance imagingessels that originated from the adventitia occurred approx- wmately 28 times more frequently than those that originated
rom the luminal side.”
In addition, Moreno and Fuster (16) have directly linked
therosclerosis and diabetes to the formation of vulnerable
laque. Recently, Mauriello et al. (22) examined 544 coro-
ary segments in 16 patients who experienced fatal coronary
vents. The results revealed the presence of diffuse, active
nflammation in the entire coronary vascular system, in
atients with both stable and vulnerable plaques.
Using animal models with dietary-induced atherosclero-
is, Williams et al. (23) showed regression of intima and
edia neovascularization after a reduction of cholesterol
eeding. In addition, Wilson et al. (24) used microcomputed
omography techniques to observe the induction of coronary
dventitial vasa vasorum in the pig and, subsequently, regres-
ion after statin therapy. Importantly, the authors noted that
he excessive growth of adventitial vasa vasorum preceded
he development of luminal plaques. Similarly, Moulton
t al. (25) studied antiangiogenesis therapies in an experi-
ental animal model of atherosclerosis.
U CAROTID IMAGING FOR IDENTIFICATION
F SURROGATE MARKERS OF ATHEROSCLEROSIS
ecent studies indicate that CU carotid imaging can be
linically useful in identifying surrogate markers of athero-
clerosis (3,26–28). These studies primarily focus on three
reas of clinical importance:
) enhancement of the carotid lumen and plaque morphology;
) improved resolution of the c-IMT of both the near and
far walls; and
) identification of atherosclerotic-related neovascular
changes within the adventitial vasa vasorum and
plaques.
he CU carotid studies of the lumen often reveal previously
ndetected irregularities, such as plaques and ulcers (Fig. 1).
irlin et al. (29) were the first to use CU agents to identify
he lumen in a series of in vitro and preclinical studies. Their
ubsequent clinical validation study in 14 patients revealed
n excellent correlation of the CU images with the results
f cerebral angiograms (30). Our laboratory has reported
dditional data suggesting the clinical utility of CU agents
or carotid lumen enhancement (26). If confirmed in larger
linical trials using other modalities (computerized tomog-
aphy angiography and magnetic resonance imaging [MRI]),
U carotid lumen imaging may reduce the need for addi-
ional invasive diagnostic procedures, in essence serving as a
oninvasive angiogram.
The CU carotid studies also enhance visualization of the
-IMT, which has served as a surrogate marker of athero-
clerosis since Pignoli and Longo (31) first reported their
ork in 1986. Numerous additional clinical trials have
alidated c-IMT as a reliable surrogate marker of athero-
clerosis. However, without contrast, c-IMT measurements
ere ineffective in approximately 7% to 27% of studies due
t
w
S
v
u
c
f
o
e
i
e
c
n
a
o
(
o
n
w
a
i
F
a
i
238 Feinstein JACC Vol. 48, No. 2, 2006
Contrast Ultrasound: Vasa Vasorum Angiogenesis July 18, 2006:236–43o the technical difficulties in reliably imaging the anterior
all of the carotid artery (32). For example, in 1998, van
wijndregt (32) reported that the near wall of the carotid
essel was not reliably identified in vitro using extravascular
ltrasound techniques. Moreover, in vitro measurement of
-IMT of the non-enhanced near wall was described as
raught with error due to inherent acoustic properties of
verlying soft tissues; in these studies, the authors compared
xtravascular ultrasound images with tissue histology and
ntravascular ultrasound images (32). In addition, Wong
igure 1. (A) This image is an example of an unenhanced carotid artery
gent, the carotid artery lumen appears echodense (white) revealing an ulce
n the previous unenhanced ultrasound examination.t al. (33) reported that conventional ultrasound, without hontrast, routinely underestimated near wall c-IMT thick-
ess by 20%. In 2003, we described the clinical use of CU
gents to enhance carotid images and improve the definition
f the carotid near wall and associated near wall c-IMT
34). Our laboratory demonstrated two distinct advantages
f imaging the carotid near wall versus the far wall: first, the
ear wall c-IMT is thicker than the far wall, particularly
hen the lumen is enhanced with ultrasound contrast
gents, and, second, the progression rate of atherosclerosis is
ncreased in the near wall versus the far wall. This finding
ound image. (B) After an intravenous injection of an ultrasound contrast
plaque along the far wall. The presence of the ulcer was not clearly definedultras
rativeas been noted by Meyer et al. (unpublished data, 1996).
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July 18, 2006:236–43 Contrast Ultrasound: Vasa Vasorum Angiogenesisotably, the variability of atherosclerosis within the vascular
rterial system was described by Bots et al. (35). Moreover,
s Hodis et al. (36,37) demonstrated, the thicker the
-IMT, the more notable the regression after statin therapy.
herefore, while validation is required, the improved visual-
zation of the near wall may serve as an additional surrogate
arker for atherosclerosis and, consequently, contribute to the
linical assessment atherosclerosis therapy (26).
Figure 2 illustrates CU visualization of the carotid artery
umen and the anterior aspect of the c-IMT, thus permit-
ing more precise measurements.
Using CU to delineate carotid adventitial vasa vasorum,
ur initial studies demonstrate that arterial nutrient flow
redominately emanates from the vasa vasorum, generating
eovascularization within the media and intima layers of
therosclerotic plaque (Fig. 3). These observations provide a
linical link between earlier pathologic studies and clinical
edicine, and support the theory that atherosclerosis devel-
ps “outside in” rather than “inside out.” Figure 4 shows
igure 2. (A) The carotid intima-media thickness of the near wall of the car
njection of an ultrasound contrast agent, the near-wall carotid intima-media th
hickness.ow CU can be used to identify neovascularization, reveal-
ng angiogenesis within a carotid artery plaque in a patient
ith cerebral transient ischemia. Due to the presence of a
ignificant carotid stenosis associated with cerebral vascular
ymptoms, the patient underwent a surgical carotid endar-
erectomy. Figure 5 reveals the presence and marked degree
f neovascularization within an unstable carotid artery
laque; the presence of neovascular vessels was highlighted
sing CD-31 stain.
Our CU carotid imaging results are consistent with MRI
tudies that identified and characterized intraplaque neovas-
ularization (38,39). Recently, Kerwin et al. (40) used MRI
o demonstrate the presence and degree of carotid plaque
eovascularization, while Takaya et al. (41) used serial MRI
tudies to demonstrate that intraplaque hemorrhage may
ead to the enlargement of a carotid artery plaque. Addi-
ionally, in a recent report by Magnoli et al. (28), the
uthors correlated the width of adventitial vasa vasorum to
-IMT using contrast-enhanced, B-flow imaging in pa-
rtery is not well visualized, limiting measurement. (B) After an intravenousotid a
ickness is identified, permitting measurement of the carotid intima-media
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Contrast Ultrasound: Vasa Vasorum Angiogenesis July 18, 2006:236–43ients with known coronary artery disease. In their report,
he authors commented that only after the administration of
ntravenous contrast agents were the adventitial vasa
asorum identified with B-flow imaging. In the control
opulation (no coronary artery disease), the administra-
ion CU agents did not enhance the vasa vasorum. This
epresents the first reported effort to use CU to quantify
he degree of neovascularization in patients with athero-
clerosis.
U CAROTID IMAGING FOR IDENTIFICATION
F REGRESSION OF ADVENTITIAL VASA VASORUM
ontrast-enhanced ultrasound carotid imaging recently
llowed us to observe regression of adventitial vasa
igure 3. Ultrasound contrast agents enhance the vessel lumen and reveal theigure 4. The presence of intraplaque angiogenesis is highlighted by the use of
xamination of a patient who had a history of a transient ischemic attack.asorum associated with atherosclerotic plaque neovascu-
arization in a 53-year-old patient with a history of
iabetes. A CU carotid examination, performed as part of
cardiovascular prevention screening, revealed distinctly
rominent vasa vasorum (Fig. 6). Despite his diabetes,
he patient was not on statin therapy at the time of the
nitial examination but subsequently was placed on a daily
tatin dose. Eight months later, a follow-up CU carotid
xamination revealed a marked decrease in the adventitial
asa vasorum (Fig. 7). While it is premature to conclude
hat CU imaging can reliably identify progression and
egression of atherosclerosis in patients, it is nevertheless
ntriguing to note that these observations are consistent
ith experimental findings reported by Heistad and
ce of intraplaque angiogenesis, emanating from the adventitial vasa vasorum.ultrasound contrast agents. The image was obtained during an ultrasound
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July 18, 2006:236–43 Contrast Ultrasound: Vasa Vasorum Angiogenesisrmstrong (42), Wilson et al. (24), Moulton (43), and
illiams et al. (23) describing the induction and subse-
uent regression of the vasa vasorum.
EOVASCULAR NOURISHMENT OF TUMORS
ontrast-enhanced ultrasound carotid imaging may be use-
ul in assessing excessive neovascularization in cancerous
umors, which resemble atherosclerotic plaques because both
umor growth and atherosclerotic plaque growth are sup-
orted by angiogenesis generated in connection with local
nd systemic growth factors. Folkman (6) first described the
ssociation between angiogenesis and tumors in 1971, contrib-
igure 5. This photomicrograph highlights the abundance of vascular end
as obtained at the time of carotid artery endarterectomy surgery and waigure 6. A prominent blood vessel (adventitial vasa vasorum) is readily identifi
iabetes. Of note, at the time of these studies, the patient was not on statin thting to the growing body of literature linking neovascular-
zation to atherosclerosis. Similarly, in 2001, Ross et al. (44)
roposed that angiogenesis stimulators are associated with
therosclerosis tumor growth. These path-breaking studies
uggest an expanded paradigm focusing on the role of
ngiogenesis in the development of atherosclerosis.
ONCLUSIONS
ur contrast carotid imaging studies appear to support
ardin’s (45) view that vascular imaging represents the next
rontier for cardiologists. Because CU agents are safe,
ommercially available, and approved for use in cardiac
al cells identified within the carotid artery plaque (Fig. 4). This specimen
ared with a CD-31 stain.ed along the near wall of the carotid artery in this 53-year-old man with
erapy.
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Contrast Ultrasound: Vasa Vasorum Angiogenesis July 18, 2006:236–43maging, physicians today can perform clinical carotid CU
maging as a research application. In patients at risk for
eveloping symptomatic atherosclerosis, CU carotid exam-
nations may help identify and quantify the presence and
egree of neovascularization of the vasa vasorum and arterial
laque, permitting a more reliable assessment of cardiovas-
ular risk. With continued investigation, CU vascular stud-
es may be routinely performed at the patient’s bedside or in
n outpatient setting, using portable and economical ultra-
ound equipment (46). Medicare reimbursement codes cur-
ently include the use of ultrasound contrast agents for
nhancement of cardiac chambers, based upon a recommen-
ation from the American Society of Echocardiography in
000 (47); a similar Medicare reimbursement code could
ollow for contrast-enhanced vascular ultrasound applications.
f interest, all comparable non-invasive imaging techniques
computed tomography, MRI, and nuclear) use enhancement
gents for delineation of anatomy and organ perfusion.
Thus, CU carotid imaging may become an indispensable
ethod of identifying atherosclerosis in its earliest stages,
hereby facilitating early intervention and ultimately reduc-
ng the incidence of heart attack and stroke. In addition, in
he future, CU technology may be used to help monitor
uturistic ultrasound-based therapies including ultrasound-
irected, site-specific delivery systems for antiangiogenic
gents (3). This could permit the targeting of organ systems
ith antiangiogenic agents and therapies for treatment of
ulnerable plaque.
eprint requests and correspondence: Dr. Steven B. Feinstein,
ush Presbyterian St. Luke’s Medical Center, Medicine, 1750
est Harrison, 1015 Jelke, Chicago, Illinois 60612. E-mail:
igure 7. After 8 months of statin therapy, the patient (Fig. 6) returned fo
dventitial vasa vasorum vessel prominently seen in Figure 6 has been sign
fter antiangiogenesis therapy with statins.feinste@rush.edu.EFERENCES
1. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to
vulnerable patient: a call for new definitions and risk assessment
strategies: part I. Circulation 2003;108:1664–72.
2. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to
vulnerable patient: a call for new definitions and risk assessment
strategies: part II. Circulation 2003;108:1772–8.
3. Feinstein SB. The powerful microbubble: from bench to bedside, from
intravascular indicator to therapeutic delivery system, and beyond.
Am J Physiol Heart Circ Physiol 2004;287:H450–7.
4. Folkman J. The vascularization of tumors. Sci Am 1976;234:58–64,
70–3.
5. Barger AC, Beeuwkes R, 3rd, Lainey LL, Silverman KJ. Hypothesis:
vasa vasorum and neovascularization of human coronary arteries. A
possible role in the pathophysiology of atherosclerosis. N Engl J Med
1984;310:175–7.
6. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl
J Med 1971;285:1182–6.
7. Barger AC, Beeuwkes R, 3rd. Rupture of coronary vasa vasorum as a
trigger of acute myocardial infarction. Am J Cardiol 1990;66:41G–3G.
8. Beeuwkes R, Barger C, Silverman K, Lainery LL. Cinemicrographic
studies of the vasa vasorum of the human coronary arteries. In: Glagov
S, Newman WP, Schaffer S, editors. Pathobiology of the Human
Atherosclerotic Plaque. New York, NY: Springer-Verlag, 1990: 425–
32.
9. Clagett GP, Robinowitz M, Youkey JR, et al. Morphogenesis and
clinicopathologic characteristics of recurrent carotid disease. J Vasc
Surg 1986;3:10–23.
0. Fryer JA, Myers PC, Appleberg M. Carotid intraplaque hemorrhage:
the significance of neovascularity. J Vasc Surg 1987;6:341–9.
1. Kumamoto M, Nakashima Y, Sueishi K. Intimal neovascularization in
human coronary atherosclerosis: its origin and pathophysiological
significance. Hum Pathol 1995;26:450–6.
2. McCarthy MJ, Loftus IM, Thompson MM, et al. Angiogenesis and
the atherosclerotic carotid plaque: an association between symptom-
atology and plaque morphology. J Vasc Surg 1999;30:261–8.
3. Mofidi R, Crotty TB, McCarthy P, Sheehan SJ, Mehigan D, Keaveny
TV. Association between plaque instability, angiogenesis and symp-
tomatic carotid occlusive disease. Br J Surg 2001;88:945–50.
4. Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage
and progression of coronary atheroma. N Engl J Med 2003;349:
llow-up contrast-enhanced carotid ultrasound examination. Note that the
tly reduced. This may represent regression of the adventitial vasa vasorumr a fo2316 –25.
11
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
243JACC Vol. 48, No. 2, 2006 Feinstein
July 18, 2006:236–43 Contrast Ultrasound: Vasa Vasorum Angiogenesis5. Fleiner M, Kummer M, Mirlacher M, et al. Arterial neovasculariza-
tion and inflammation in vulnerable patients: early and late signs of
symptomatic atherosclerosis. Circulation 2004;110:2843–50.
6. Moreno PR, Fuster V. New aspects in the pathogenesis of diabetic
atherothrombosis. J Am Coll Cardiol 2004;44:2293–300.
7. Alpern-Elran H, Morog N, Robert F, Hoover G, Kalant N, Brem S.
Angiogenic activity of the atherosclerotic carotid artery plaque. J Neu-
rosurg 1989;70:942–5.
8. Carlier S, Kakadiaris IA, Dib N, et al. Vasa vasorum imaging: a new
window to the clinical detection of vulnerable atherosclerotic plaques.
Curr Atheroscler Rep 2005;7:164–9.
9. Martin JF, Booth RF, Moncada S. Arterial wall hypoxia following
hyperfusion through the vasa vasorum is an initial lesion in athero-
sclerosis. Eur J Clin Invest 1990;20:588–92.
0. Wolinsky H, Glagov S. Nature of species differences in the medial
distribution of aortic vasa vasorum in mammals. Circ Res 1967;20:
409–21.
1. Koster W. Endarteritis and arteritis. Berlin Klin Wschr 1876;13:
454–5.
2. Mauriello A, Sangiorgi G, Fratoni S, et al. Diffuse and active
inflammation occurs in both vulnerable and stable plaques of the entire
coronary tree: a histopathologic study of patients dying of acute
myocardial infarction. J Am Coll Cardiol 2005;45:1585–93.
3. Williams JK, Armstrong ML, Heistad DD. Vasa vasorum in athero-
sclerotic coronary arteries: responses to vasoactive stimuli and regres-
sion of atherosclerosis. Circ Res 1988;62:515–23.
4. Wilson SH, Herrmann J, Lerman LO, et al. Simvastatin preserves the
structure of coronary adventitial vasa vasorum in experimental hyper-
cholesterolemia independent of lipid lowering. Circulation 2002;105:
415–8.
5. Moulton KS, Vakili K, Zurakowski D, et al. Inhibition of plaque
neovascularization reduces macrophage accumulation and progression
of advanced atherosclerosis. Proc Natl Acad Sci U S A 2003;100:
4736–41.
6. Macioch JE, Katsamakis CD, Robin J, et al. Effect of contrast
enhancement on measurement of carotid artery intimal medial thick-
ness. Vasc Med 2004;9:7–12.
7. Neems RFM, Goldin M, Dainauskas J, et al. Real-time contrast
enhanced ultrasound imaging of the neovascularization within the
human carotid plaque. J Am Coll Cardiol 2004;43:374A.
8. Magnoli MCS, Melisurgo G, De Dominicis D, et al. Contrast
enhanced B-flow imaging for the evaluation of periadventitial vasa
vasorum in humans. Presented at: Proceeding of the 11th European
Symposium on Ultrasound Contrast Imaging; Rotterdam, the Neth-
erlands, 2006.
9. Sirlin CB, Lee YZ, Girard MS, et al. Contrast-enhanced B-mode US
angiography in the assessment of experimental in vivo and in vitro
atherosclerotic disease. Acad Radiol 2001;8:162–72.
0. Kono Y, Pinnell SP, Sirlin CB, et al. Carotid arteries: contrast-
enhanced US angiography—preliminary clinical experience. Radiology
2004;230:561–8.1. Pignoli P, Longo T. Ultrasound evaluation of atherosclerosis. Meth-
odological problems and technological developments. Eur Surg Res
1986;18:238–53.
2. van Swijndregt ADM. An in-vitro evaluation of the line pattern of the
near and far walls of carotid arteries using B-mode ultrasound.
Ultrasound Med Biol 1996;22:1007–15.
3. Wong M, Edelstein J, Wollman J, Bond MG. Ultrasonic-pathological
comparison of the human arterial wall. Verification of intima-media
thickness. Arterioscler Thromb 1993;13:482–6.
4. Rajaram V, Pandhya S, Patel S, et al. Role of surrogate markers in
assessing patients with diabetes mellitus and the metabolic syndrome
and in evaluating lipid-lowering therapy. Am J Cardiol 2004;93:32C–
48C.
5. Bots ML, de Jong PT, Hofman A, Grobbee DE. Left, right, near or
far wall common carotid intima-media thickness measurements: asso-
ciations with cardiovascular disease and lower extremity arterial ath-
erosclerosis. J Clin Epidemiol 1997;50:801–7.
6. Hodis HN, Mack WJ, LaBree L, et al. Reduction in carotid arterial
wall thickness using lovastatin and dietary therapy: a randomized
controlled clinical trial. Ann Intern Med 1996;124:548–56.
7. Hodis HN. Reversal of atherosclerosis with therapy: update of coro-
nary angiographic trials. Adv Pharmacol 1996;35:307–20.
8. Fuster V. The evolving role of CT and MRI in atherothrombotic
evaluation and management. Nat Clin Pract Cardiovasc Med 2005;2:323.
9. Fuster V, Fayad ZA, Moreno PR, Poon M, Corti R, Badimon JJ.
Atherothrombosis and high-risk plaque: part II: approaches by non-
invasive computed tomographic/magnetic resonance imaging. J Am
Coll Cardiol 2005;46:1209–18.
0. Kerwin W, Hooker A, Spilker M, et al. Quantitative magnetic
resonance imaging analysis of neovasculature volume in carotid ath-
erosclerotic plaque. Circulation 2003;107:851–6.
1. Takaya N, Yuan C, Chu B, et al. Presence of intraplaque hemorrhage
stimulates progression of carotid atherosclerotic plaques: a high-
resolution magnetic resonance imaging study. Circulation 2005;111:
2768–75.
2. Heisted DD, Armstrong ML. Blood flow through vasa vasorum of
coronary arteries in atherosclerotic monkeys. Arteriosclerosis 1986;6:
326–31.
3. Moulton KS. Plaque angiogenesis and atherosclerosis. Curr Athero-
scler Rep 2001;3:225–33.
4. Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, Ginsburg GS.
Atherosclerosis: a cancer of the blood vessels? Am J Clin Pathol
2001;116 Suppl:S97–107.
5. Gardin JM. Vascular ultrasound: the next frontier for the echocardi-
ographer. J Am Soc Echocardiogr 2005;18:24A–6A.
6. Gepner AD, Korcarz CE, Aeschlimann SE, et al. Validation of a
carotid intima-media thickness border detection program for use in an
office setting. J Am Soc Echocardiogr 2006;19:223–8.
7. Mulvagh SL, DeMaria AN, Feinstein SB, et al. Contrast echocardi-
ography: current and future applications. J Am Soc Echocardiogr
2000;13:331–42.
